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Abstract
Background: China rolled out the national essential medicines policy (NEMP) in primary care in 2009 and led to some 
unintended consequences including unavailability of essential medicines. This study examined patients’ coping behaviors 
to these unintended consequences of NEMP as well as the potential impact on primary care system development in 
Hangzhou, a developed city of China. 
Methods: We conducted qualitative interviews and surveys with service users, primary care physicians (PCPs), and 
specialists in tertiary hospitals. Qualitative findings informed the design of the survey questionnaires. Main outcomes 
included patients’ coping behaviors after the NEMP implementation, as well as providers’ perceptions of NEMP’s impact 
on primary care development. Thematic analysis of the qualitative data and descriptive analysis of the survey data were 
conducted.
Results: Unintended effects of NEMP included frequent unavailability of certain essential drugs, leading to patient flow 
from primary care to hospital outpatient clinics for drug refills, difficulties in the provision of continuing care in primary 
care, as well as compromised patient trust in PCPs. In total, 1248 service users completed the questionnaires. A total of 
132 (10.6%) were aged 60 years or above. Among 153 (57.7%) of the 265 who had some chronic condition(s) and needed 
long-term medication treatment, 60.1% went to hospitals for refills. Four-hundred sixty PCPs and 651 specialists were 
recruited. Among 404 PCPs who were aware of the NEMP policy implementation in their facility, 169 (41.8%) reported 
that there was often a shortage of drugs at their facilities and 44 (10.9%) reported always. Moreover, 68.6% of these PCPs 
thought that the NEMP could not meet their patients’ needs. Further, 44.2% (220/498) of specialists who were aware of 
the NEMP policy in primary care reported that they often heard patients complaining about the policy. In total, 53.1% of 
PCPs and 42.4% of specialists disagreed that NEMP helped direct patient flow to community-based care. 
Conclusion: NEMP’s unintended effects undermined patients’ utilization of primary care in a developed city in China 
and led to unnecessary hospital visits. Countermeasures are needed to mitigate the negative impacts of NEMP on the 
primary care system. 
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Implications for policy makers
• The implementation of national essential medicines policy (NEMP) in primary care has unexpectedly led to patient flow from primary care to 
hospital-based services for drug refills, causing health resources wastage. 
• The shortage of essential drugs created difficulties in primary care physicians’ (PCPs’) provision of continuous care and prescription autonomy, 
which further compromised patient trust in PCPs.
• In the context of intensive primary care reforms in China, evaluation of the impact of NEMP on patients’ utilization of primary care services 
merits more attention from policy-makers.    
Implications for the public
This study may help informing the public about the status quo of the National Essential Medicines Policy (NEMP) and mitigate to some extent 
the public distrust in primary care physicians (PCPs) due to misinterpretation of the unavailability of essential drugs in primary care. The study 
findings also reflected the public’s views towards the NEMP, which are often neglected by policy-makers. Having the public’s voice heard by a wider 
community, potentially including health reformers, provides an opportunity to incorporate their feedback into future NEMP reforms.
Key Messages 
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Background 
Since the marketization of health services in 1980s, drug sales 
have been an important source of revenue for health facilities 
in the public sector in China, accounting for more than 40% 
of a health facility’s income.1,2 As a result, over-prescription 
of profitable drugs and irrational drug use by medical 
professionals are widespread.3 To address the challenge of 
irrational drug prescriptions and ensure affordability of 
health services, one of the top 5 priorities of China’s health 
reforms was the rollout of a national essential medicines 
policy (NEMP) in primary care,4 which aims to ensure access 
to safe, effective, affordable medicines for all.5 In primary 
care facilities that have implemented NEMP, profit margins 
of drugs enlisted are not allowed (ie, zero-profit policy) 
and all drugs are covered by health insurance schemes. The 
reimbursement rates for essential drugs are significantly 
higher than those of non-essential drugs and primary care 
physicians (PCPs) are encouraged to use the listed essential 
medicines. 
NEMP is now implemented in all government-run primary 
care facilities in China. In the 2012 national essential medicines 
list for primary care, 520 generic medicines were included 
based on disease epidemiology, clinical use, affordability, and 
availability of medicines, including 317 western medicines 
and 203 Chinese medicines.6 Provinces were allowed to have 
additional drugs on the list based on their own financial 
capabilities. Provincial level online bidding system and 
centralized procurement system for essential drugs has been 
established to reduce the inflated drug prices that were due 
to intermediate procedures. The central government sets 
the ceiling prices for essential drugs, and pharmaceutical 
companies then bid online. The winning companies are 
added to a list of providers of essential drugs on a provincial 
online platform. The online platform facilitates the central 
procurement and distribution of drugs between primary care 
facilities and pharmaceutical manufacturers. 
Effects of the NEMP have been widely evaluated. The vast 
majority of publications focused on the impact of NEMP on 
medical expenditures,7-14 rational use of medications,8,11,14-16 
availability and affordability of essential medicines,9,14,17-19 
by examining prescription data from various tiers of health 
facilities in the public sector as well as surveying availability 
of essential medicines in pharmacies in the private sector.17 
Poor availability of essential medicines has been frequently 
reported as an unintended effect of NEMP implementation.19 
However, voice of PCPs and patients have been neglected. 
In the past 5 years, only one 2016 study examined PCP and 
patient satisfaction with NEMP.20 Further, a limited number 
of Chinese publications reported increased service use 
both at primary care level and hospitals after the NEMP 
implementation.21,22 But none examined the patient flow 
between different tiers of health facilities and what factors 
might be driving the patient flow. How primary care patients 
cope with the unavailability of essential medicines and 
how the primary care system might be affected merit more 
research. 
Primary care is the health system’s bedrock. The 
benefits of good primary care to health systems include 
improved population health outcomes, increased health 
system efficiency, and reduced health inequality between 
different income groups.23,24 China has a 3-tier healthcare 
system. Primary care facilities are expected to deal with 
common, simple conditions, while secondary and tertiary 
hospitals provide specialist referral care. Nevertheless, it 
is not mandatory for patients to go through primary care 
facilities, and patients can bypass primary care and see 
specialists at secondary and tertiary hospitals. Given most 
quality resources, including physicians with more formal 
medical education, are concentrated in hospitals due to the 
competition between different tiers of health facilities,25 
many patients prefer hospital outpatient services which are 
widely believed to have better quality.26,27 China’s primary 
care system is facing challenges in attracting and retaining 
patients. Underutilization of primary care and abuse of 
hospital resources are substantial challenges for China’s health 
system.25,28 Therefore, to improve the health system efficiency, 
another top priority of the health reforms is to strengthen the 
primary care system with a goal of establishing an effective 
gatekeeping mechanism.4 Health reform policies complexly 
interact each other and their impact on one another should 
be evaluated. 
This study aimed to examine, from service users and 
medical professionals perspectives, patients’ coping behaviors 
to the unavailability of essential medicines at community 
level, and the effects of NEMP on primary care system in the 
Chinese settings. We adopted a mixed methods approach, 
using both qualitative interviews and subsequent surveys with 
the service users, PCPs, and specialists. The study findings 
have implications for China’s future NEMP and primary care 




This research project consisted of 2 phases—Phase 1 (a 
qualitative study) and Phase 2 (a quantitative study). The 
study design was published elsewhere.26,29 In Phase 1, semi-
structured individual interviews and focus group discussions 
were conducted to elicit detailed accounts from both service 
users and service providers. Topic guides were developed for 
interviews based on literature review. In Phase 2, questionnaire 
surveys with service users and physicians were carried out to 
triangulate findings that emerged from the qualitative study. 
The Phase 1 qualitative study informed the design of the 
questionnaire. 
Study Population 
The developed capital city of Zhejiang province, Hangzhou, 
had a population of 6.95 million in its eight districts in 
2014-2015 when data were collected. In 2014, there were 92 
comprehensive hospitals, 120 community health centers, 
and 905 satellite stations. The target populations of this 
study were the general public residing in the city, and 
medical professionals working at comprehensive hospitals 
and community health facilities (including centers and their 
affiliated satellite stations) in Hangzhou.
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Sampling and Data Collection
Qualitative Study 
The qualitative study (Phase 1) was conducted from September 
2014 to April 2015. Purposive sampling was adopted to recruit 
participants. A local researcher, who had strong connections 
with local health authorities, was identified and interviewees 
were approached based on professional networks. 
The sampling framework for the service users included 
their age, education levels, income levels, and whether 
they were diagnosed as having chronic conditions. Group 
interviews were mainly arranged based on age groups. 
Sampling strategy for medical professionals encompassed the 
following characteristics: clinical settings, facility location, 
and professional ranking. Physicians were grouped based 
on their professional ranking to avoid hierarchy in the same 
group. Recruitment ceased when data saturation was reached.
We asked patients about their experiences of purchasing 
medications at community health facilities and doctors about 
their views of NEMP’s impact on patients. The interviewers 
were unknown to most participants and the researchers 
maintained their neutrality during the discussions. Most 
interviews lasted around 60 minutes and took place in private 
rooms. All interviewees were informed of the purpose of 
the study, and anonymity and confidentiality were assured. 
Consent was obtained before the interviews. An incentive of 
50 Chinese Yuan (US$7.22) was offered to each participant as 
a token of gratitude. 
Quantitative Study
The quantitative study (Phase 2) was conducted from July 
to September 2015. Multi-stage stratified random sampling 
was used to recruit service users.26 We asked them about their 
demographic backgrounds, whether they had any chronic 
conditions that required long-term medication treatment, 
availability of medications at primary care facilities, and visits 
to hospital facilities. 
We used multi-stage stratified sampling to sample PCPs 
from community health facilities.29 A total of 12 community 
health centers were included and all PCPs present on 
surveying days were invited. An invitation letter with the 
link to the online survey sealed within an envelope was 
distributed to PCPs. Three comprehensive tertiary hospitals 
in central Hangzhou were conveniently selected for recruiting 
specialists. Specialists present on surveying days were invited 
the same way as PCPs. The online questionnaire could be 
filled in with an electronic device by scanning a QR code 
or inputting the link provided in the letter in a browser. We 
asked physicians about their demographic information, views 
towards availability of essential drugs, and NEMP’s impact on 
patient flow. 
Respondents were told that the survey was anonymous 
and voluntary. No personal particulars were recorded, and 
confidentiality was strictly protected. A 5-Yuan (US$0.72) 
incentive was provided to each respondent.
Data Analysis
Interviews were audio recorded and transcribed. One of 
the authors checked the accuracy of the transcripts. A 
thematic framework analysis was conducted using NVivo 12. 
Codebooks were developed based on the first 2 interviews 
and then were used to guide the rest of the analysis. Two 
investigators coded the data independently. The coding 
consistency between the 2 sets was checked. Discrepancies 
were then discussed and resolved by the 2 investigators. 
Quotes were translated from Chinese into English. The 
key themes that emerged were then incorporated into the 
questionnaire for the survey. The survey data were analyzed 
using SPSS Version 25. Descriptive analysis was carried out 
to describe respondents’ views towards NEMP policy and its 
impact on service utilization. 
Results 
Qualitative Findings From Service Users 
We conducted 13 semi-structured individual interviews and 
6 focus group discussions (6 to 8 participants per group). 
Among the participants, 44.4% were men. The mean age of all 
participants was 52.6 years (standard deviation [SD] = 17.0). 
The most frequent complaint revealed by service users was the 
unavailability of medications at community health facilities, 
including some commonly used medications and imported 
ones (Supplementary file 1, quotations 1-3). Service users 
said that this caused inconvenience, and they had to go to a 
hospital just to get medications. The perceived unavailability 
of certain essential medicines at primary care facilities had a 
negative impact on service users’ intention to use community-
based care (Supplementary file 1, quotation 4). 
Quantitative Findings From Service Users 
We recruited 1248 service users and their characteristics were 
reported elsewhere.26 Women accounted for 49.4% of the total 
respondents (Table 1). Most respondents (769, 61.6%) were 
aged below 40 years and 132 (10.6%) were aged 60 years or 
above. Totally, 1037 (83.1%) reported being covered by some 
health insurance. Among all, 265 (21.2%) reported some 
chronic condition(s) that had been diagnosed earlier, and 
153 (57.7%) of them needed long-term medication treatment. 
Among these 153 respondents, 60.1% went to hospitals for 
drug refills.
Qualitative Findings From Physicians 
Five focus group discussions with PCPs at community 
health facilities (4 to 8 PCPs in each group) and 2 groups 
with specialists from 3 tertiary hospitals (6 and 8 specialists 
respectively) were conducted. Semi-structured individual 
interviews were conducted with 13 PCPs and 8 specialists. 
Sixty-one percent of the participants were men. The mean age 
of all physicians was 34.3 years (SD = 5.8).
The interviews with PCPs also revealed the unavailability 
of certain drugs for common diseases. They perceived 
clinically unmet patients’ needs due to the limited number 
of drugs available at community health facilities, especially 
among patients with multiple morbidities (Supplementary 
file 2, quotation 1). Patients then had to go to a hospital for 
medications they needed. The specialists’ experiences and 
perceptions triangulated the service users’ and the PCPs’ 
views. A specialist working in one of the tertiary hospitals 
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complained that she had to write prescriptions for patients to 
get their refills (Supplementary file 2, quotation 2). 
The PCPs articulated that it was the NEMP policy as well 
as its accompanying regulations that led to the above issues. 
Such unexpected effects were conflicting with the goal of 
promoting primary care’s gatekeeper role (Supplementary file 
2, quotations 3 and 4). Reasons for why the implementation of 
NEMP led to such coping behaviors were discussed. One major 
factor was the exclusion of imported medications to ensure 
the affordability of essential drugs. Imported medications 
were regarded to have better quality. However, primary care 
facilities were unable to provide refills of imported drugs 
that were prescribed by specialists (Supplementary file 2, 
quotations 5 and 6). Such an issue also compromised the 
patient’s trust in primary care providers’ capability to cure 
patients, as was illustrated by a PCP (Supplementary file 2, 
quotation 7). 
Quantitative Findings From Physicians
A total of 1111 physicians completed the questionnaire, 
including 460 PCPs from community health facilities and 651 
hospital specialists (Table 2). Characteristics of the physicians 
were reported elsewhere.29 The mean age was 34.5 years (SD 
= 7.5). Women accounted for over 60% of the respondents 
in both groups. Overall, they had an average of 10.7 years 
of practice (SD = 8.3). Specialists, in general, had higher 
educational attainments than PCPs (P <.001, Pearson chi-
square test).
PCPs’ Views 
Table 3 shows PCPs’ views towards the NEMP policy. Over 
88% of PCPs were aware that the NEMP policy had been 
implemented in their facility, with most of them reporting the 
implementation being over 2 years before the survey. Among 
the 404 PCPs who were aware of the policy, up to 278 (68.8%) 
thought that the NEMP could not meet their patients’ needs 
of medicine. Out of 404, 169 (41.8%) reported that there was 
often a shortage of drugs at their facilities and 44 (10.9%) 
reported always. Only a third (135, 33.5%) considered NEMP 
as effective in directing patients to community-based care, 
while 214 (53.1%) disagreed.
Specialists’ Views
Specialists’ views of the effects of NEMP are shown in 
Table 4. Slightly over 3-quarters (76.5%) were aware of the 
implementation of NEMP at community health facilities near 
their hospital. Among them, more than half (53.5%) thought 
that NEMP failed to meet patients’ needs in primary care. 
One-third perceived that there was often/always a shortage 
of drugs. A total of 220 (44.2%) reported that they often 









60 or above 132 (10.6)
Missing 49 (3.9)
Education
High school or less 694 (55.6)













Not insured 140 (11.2)
Insured 1037 (83.1)
Missing 71 (5.7)
Diagnosed chronic conditions 265 (21.2)
Needed long-term medication (n = 265) 153 (57.7)
Availability of medications at the community (n = 153) 72 (47.1)
Went to hospitals to refill medications (n = 153) 92 (60.1)






n = 651 P Value
Age (mean, SD) 34.5 (7.5) 36.4 (6.8) 33.2 (7.7) <.001
Years of practice (mean, SD) 10.7 (8.3) 13.5 (8.1) 8.7 (7.9) <.001
Gender 0.09
Male 392 (35.3) 143 (31.1) 249 (38.2)
Female 691 (62.2) 289 (62.8) 402 (61.8)
Missing 28 (2.5) 28 (6.1) 0 (0)
Education <.001
Post-secondary or less 158 (14.2) 105 (22.8) 53 (8.1)
University or higher 942 (84.8) 344 (74.8) 598 (91.9)  
Missing 11 (1.0) 11 (2.4) 0 (0)
Abbreviations:  PCPs, primary care physicians; SD, standard deviation.
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heard patients complaining about the NEMP policy. Overall, 
slightly over a third (181, 36.3%) agreed that NEMP helped 
divert patients to primary care, while 211 (42.4%) disagreed.
Discussion 
NEMP is an important strategy to ensure accessibility and 
affordability of safe and effective drugs in China’s primary 
care system. Evaluation of the impact of NEMP on the 
development of primary care system is however lacking. 
This study extends the literature by identifying patients’ 
coping behavior to unavailability of essential medicines by 
visiting hospital outpatient services, leading to unnecessary 
patient flow from primary care to hospital-based care. We 
found other negative impact of NEMP on the primary care 
system including difficulty in providing continuing care and 
compromised patient trust in PCPs. 
Our study found that the unavailability of essential 
medicines affected patient access to medications in primary 
care and caused patient complaints. This is consistent with 
an earlier study which found patient dissatisfaction with the 
quantity of essential medicines in another province, Ningxia.20 
Exclusion of medicines with higher effectiveness but more 
expensive, reduced quality and quantity of essential medicines 
to avoid financial loss by pharmaceutical manufacturers 
were frequently reported contributing factors.19 Our study 
also found that people from developed urban areas had 
expectations of medicines of better effectiveness, such as 
imported ones. In addition, many Chinese patients prefer 
hospital-based outpatient services for an initial diagnosis 
and management plan.26 However, it is not mandatory for 
hospital specialists to prescribe essential medicines,18 and 
they often prescribe medications which are believed to have 
better quality but less likely to be available in primary care, 
causing challenges for PCPs to refill the same medicines. 
PCPs may also find it challenging to change the medication 
regime because of patient distrust.29 As a result, both patients’ 
help-seeking autonomy and PCPs’ prescribing autonomy 
are compromised to some extent, contributing to discontent 
among both groups. 
As a result, patients, especially those with chronic 
conditions who need long-term medical treatment, 
adapted their healthcare seeking pattern by visiting hospital 
outpatient clinics for drug refills. Over 60% of service user 
respondents who needed long-term medications reported 
visiting hospitals for drug refills. PCPs and hospital specialists 
conveyed the same message. Being an alternative for patients 
Table 3. PCPs’ Views Towards the Effects of the Essential Drug List on Patients’ Help-Seeking
No. %
For how long has essential drug list policy been implemented at your workplace? (n = 460)
Not implemented yet 7 1.5
Within 1 year 20 4.4
1-2 years 39 8.6
2-4 years 176 38.9
>4 years 163 36.1
Don't know 47 10.4
From the medical perspective, to what degree can the essential drugs satisfactorily meet patients' needs? (n = 404)




Very satisfactory 5 1.2
Don't know 2 0.5





Don't know 7 1.7





Does the current essential drug list policy help direct patients to community-based care? (n = 404)
Yes 135 33.5
No 214 53.1
Don't know 54 13.4
Abbreviation: PCPs, primary care physicians.
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to refill, pharmacies are facing the similar challenge of 
unavailability of some essential medicines.19 They may also 
be less appealing owing to lower patient trust and patients’ 
preference for a follow-up medical consultation at the same 
time. This unavailability consequently drove many patients 
away from community-based primary care facilities to 
hospitals, potentially leading to wastage of hospital resources. 
Such a trend of patient flow runs counter to other goals of the 
national health reforms such as promoting primary care and 
reducing wastage of hospital resources.4 
Lastly, other unintended impact of NEMP on China’s 
primary care system were compromised patient trust in PCPs 
and difficulty in provision of continuing care by PCPs. A 
2013 study reported that primary care doctors were scolded 
by patients for not being able to prescribe medicines they 
needed.30 Our participants further revealed that unavailability 
of essential drugs negatively affected service users’ trust in 
PCPs’ clinical competence. Patient trust is essential to the 
physician-patient relationship and for retaining patients in 
primary care. Due to less formal medical education among 
PCPs and concentration of qualified physicians in hospitals, 
China’s primary care system is facing challenges in gaining 
patient confidence and attracting patients to community-
based facilities.31 Such an unanticipated impact on patient 
trust may further compound the PCP-patient relationship 
issue. Providing effective continuing care to patients is a 
key function of a healthy primary care system. Our study 
demonstrated that many patients intended to seek follow-up 
care at community health facilities but were deterred away to 
hospitals. The continuity of care at primary level deteriorated 
to some extent because of the unavailability of essential 
medications. 
To mitigate the negative impact on primary care system and 
retain patients at the community level, actions are needed. 
The National Health Commission of the People’s Republic 
of China increased the number of essential drugs from 520 
to 685 in the most updated version of NEMP in 2018.32,33 In 
addition to this, various provincial health bureaus are also 
gradually relaxing the policy in primary care. For example, 
over 10 provinces and regions including Zhejiang, Chongqing, 
Gansu, and Shandong, have partially relaxed the NEMP 
and allowed 30%-50% of their drugs to be non-essential 
in primary care facilities.34 Public awareness campaign to 
improve service users’ understanding of the NEMP may be 
helpful to mitigate the risk of deteriorated distrust in PCPs. 
Patient preferred sources for first-contact care should also be 
considered in future policy changes given the discrepancies in 
NEMP implementation and disease profile between primary 
care facilities and hospitals. Taking economic backgrounds of 
local populations into account, allowing more non-essential 
drugs in primary care facilities, and further strengthening the 
role of pharmacies for drug refills in the private sector may be 
Table 4. Specialists’ Views Towards the Effects of the Essential Drug List on Patients’ Help-Seeking
 No. %
Has essential drug list policy been implemented at community health facilities in the area where your hospital is located? (n = 651)
Yes 498 76.5
No 37 5.7
Don't know 116 17.8
From the medical perspective, to what degree can the essential drugs satisfactorily meet patients' needs in primary care? (n = 498)




Very satisfactory 6 1.2
Don't know 18 3.6





Don't know 97 19.5





Does the current essential drug list policy help direct patients to community-based care? (n = 498)
Yes 181 36.3
No 211 42.4
Don't know 106 21.3
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solutions to better meet patients’ needs in urban cities. Actions 
are also necessary to maintain good quality of essential 
medicines produced by pharmaceutical companies and 
secure supply to both primary care facilities and pharmacies. 
Our study has some limitations. First, we conducted the 
study in a developed urban area in China. The study results 
may not be representative of other poorer regions in the 
country. However, our findings may reflect the situation in 
Chinese cities with relatively better-off economic conditions. 
Second, self-administered questionnaire surveys might 
introduce recall bias regarding past experiences. Most items 
solicited respondents’ views towards their recent experiences 
and recall bias is likely to be inconsequential. Additionally, 
we recruited a slightly lower proportion of people aged 60 or 
above and the findings should be interpreted with caution. 
Third, we were not able to obtain more concrete service 
utilization data owing to lack of access to government and 
clinical data. Self-reported responses at a certain point in time 
have limited power to reflect the changing pattern of dynamic 
service utilization. However, this study provides a snapshot 
of the effects of NEMP on service use and service delivery in 
primary care settings from both service users’ and providers’ 
perspectives and can serve as the starting point of monitoring 
the impact on primary care system. Lastly, random sampling 
of hospital specialists was challenging. There was a selection 
bias in sampling specialists and the representativeness of 
specialist views may be compromised. 
Conclusion
NEMP policy is a promising strategy to improve accessibility 
and affordability of medicines in low- and middle-income 
countries. Our study investigated NEMP’s impact on 
primary care system in China. We found that the unintended 
unavailability of essential medicines consequently deterred 
patients who needed long-term medical treatments from 
attending primary care, leading to unnecessary hospital 
outpatient visits for drug refills, as well as wastage of hospital 
resources. Discontent from both patients and service 
providers was evident. Such discontent might consequently 
compound the issue of building patient confidence in PCPs 
and bring more challenges in establishing effective gate-
keeping mechanism and delivering continuing care at primary 
care level. Actions are needed to mitigate the negative impact 
of NEMP on the development of primary care system, and 
close monitoring of the impact of NEMP on patient service 
utilization is necessary.
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